Summary
Cerba HealthCare SAS (Cerba), formerly Cerba European Lab S.A.S. is a biotechnology company that offers biological diagnosis solutions. The company provides medical biology laboratories and specialized biology laboratory programs. It conducts medical biology tests and clinical trials through its multidisciplinary platforms. Cerba offers services in the areas of anatomy, autoimmunity, allergology, cytogenetics, foetal biochemistry, sperm biochemistry, oncology, diabetology, endocrinology, enzymology, haemostasis, infectology, parasitology, and pathology, among others. The company offers services to doctors and pharmaceutical companies through its network of laboratories and collection centers. Cerba is headquartered in Saint Ouen l’Aumone, France.
Cerba HealthCare SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cerba HealthCare SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cerba HealthCare SAS, Medical Devices Deals, 2011 to YTD 2017 9
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Partners Group and PSP Investments to Acquire Cerba HealthCare from PAI Partners 11
Partnerships 12
OncoDNA Enters into Distribution Agreement with Laboratoire Cerba 12
Merger 12
Ketterthil Lab Merges With Cerba European Lab 12
Debt Offering 13
Cerba European Lab Prices Private Placement Of Notes Due 2022 For US$110.5 Million 13
Cerba European Lab Completes Public Offering Of Notes Due 2022 For US$485 Million 14
Cerba HealthCare SAS - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Key Facts 1
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cerba HealthCare SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cerba HealthCare SAS, Deals By Therapy Area, 2011 to YTD 2017 8
Cerba HealthCare SAS, Medical Devices Deals, 2011 to YTD 2017 9
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners Group and PSP Investments to Acquire Cerba HealthCare from PAI Partners 11
OncoDNA Enters into Distribution Agreement with Laboratoire Cerba 12
Ketterthil Lab Merges With Cerba European Lab 12
Cerba European Lab Prices Private Placement Of Notes Due 2022 For US$110.5 Million 13
Cerba European Lab Completes Public Offering Of Notes Due 2022 For US$485 Million 14
Cerba HealthCare SAS, Key Competitors 16
Cerba HealthCare SAS, Key Employees 17
Cerba HealthCare SAS, Other Locations 18
Cerba HealthCare SAS, Subsidiaries 18
List of Figures
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cerba HealthCare SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cerba HealthCare SAS, Medical Devices Deals, 2011 to YTD 2017 9